CUBE vs ELAB · P/E 25, rev $1.07B vs rev $1.7M
CubeSmart (CUBE) versus Elevai Labs, Inc. Common Stock (ELAB) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Elevai Labs, Inc. Common Stock (ELAB) is a biotechnology company listed on NASDAQ.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported ELAB revenue for 2023-12-31 was $1.7M. Net income was -$4.3M. Revenue was up 123.5% from 2022-12-31 to 2023-12-31. ELAB currently screens at market cap $6.5M.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. ELAB currently screens at market cap $6.5M.
Not investment advice. Open the CUBE and ELAB stock pages for the full models.
Not investment advice.